CTKB
Cytek Biosciences, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Fund move
Fund move
Last report0 of 7 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
−0.48%
vs ±72.4% implied · ×0.01
shaded = implied · ▲▼ = realized
Cytek Biosciences, Inc.
6.13
No thesis.
Expected move
No implied move.
No implied move.
No implied move.
Linked news
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | BlackRockBlackRockindex-like | $42.4M | 11.75% | −43.68% | |
| 2 | Millennium ManagementMillennium | $41.4M | 11.46% | +48.42% | |
| 3 | Boston PartnersBoston Partners | $33.9M | 9.40% | +32.02% | |
| 4 | Hillhouse Capital AdvisorsHillhouse Capital | $29.5M | 8.17% | 0.00% | |
| 5 | Topline Capital ManagementTopline | $27.8M | 7.71% | −11.06% | |
| 6 | Vanguard Capital ManagementVanguardindex-like | $21.9M | 6.06% | +3.71% | |
| 7 | Geode Capital ManagementGeodeindex-like | $13.6M | 3.75% | +7.96% | |
| 8 | Dimensional Fund AdvisorsDimensional | $11.6M | 3.21% | −1.77% | |
| 9 | State StreetState Streetindex-like | $11.4M | 3.15% | −37.77% | |
| 10 | Goldman Sachs GroupGoldman Sachs | $9.6M | 2.66% | −7.56% | |
| 11 | Royce & AssociatesRoyce & | $9.2M | 2.55% | +26.74% | |
| 12 | Russell Investments GroupRussell | $6.7M | 1.85% | +11.13% | |
| 13 | Acadian Asset ManagementAcadian | $6.1M | 1.69% | +244.88% | |
| 14 | Bank of AmericaBank of America | $5.8M | 1.61% | +30.35% | |
| 15 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $5.1M | 1.40% | −50.62% | |
| 16 | Charles Schwab Investment ManagementCharles Schwabindex-like | $4.8M | 1.32% | −2.84% | |
| 17 | Northern TrustNorthern Trustindex-like | $4.4M | 1.23% | −0.19% | |
| 18 | HRT FinancialHRT Financial | $4.4M | 1.22% | +140.98% | |
| 19 | Arrowstreet Capital, Limited PartnershipArrowstreet Capital, Limited Partnership | $4.3M | 1.19% | +204.41% | |
| 20 | Jane Street GroupJane Street | $4.0M | 1.11% | new | |
| 21 | Tudor Investment Corp ET ALTudor Investment Corp ET AL | $3.7M | 1.03% | +161.26% | |
| 22 | AQR Capital ManagementAQR | $3.6M | 1.00% | −10.78% | |
| 23 | Vanguard Fiduciary TrustVanguard Fiduciary Trustindex-like | $3.3M | 0.91% | +3.30% | |
| 24 | Citadel AdvisorsCitadel | $3.2M | 0.89% | +49.41% | |
| 25 | Morgan StanleyMorgan Stanley | $3.1M | 0.86% | −59.17% |
153 managers report $361.1M of Cytek Biosciences on form 13F for the quarter ended Jun 30 '26. 18 of them hold 80% of it; BlackRock is largest at 11.75%.